Ignite Creation Date:
2024-05-06 @ 3:30 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04652206
Status:
UNKNOWN
Last Update Posted:
2021-12-29
First Post:
2020-11-20
Brief Title:
Clinical Trial to Investigate Safety Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients
Sponsor:
Scandion Oncology AS
Organization:
Scandion Oncology AS
Organization Data
Organization:
Scandion Oncology AS
Class:
INDUSTRY
Study ID:
SCO101-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Scandion Oncology AS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Alcedis GmbH | INDUSTRY |